Prodia (PRDA IJ) - A Standout in Diagnostics
Prodia (PRDA IJ) stands out in terms of its strong market positioning and track record together with attractive valuations, especially versus...
577 Views
Medikaloka Hermina (HEAL IJ) - Forging Ahead Beyond COVID
Medikaloka Hermina (HEAL IJ) is unique in Indonesia for its focus on women and children, which makes it a resilient performer plus more than half...
547 Views
Prodia (PRDA IJ) - Injecting Digital Health
Prodia looks cheap as forecast to return to growth over the next two years, with +11% EPS growth forecast for FY2023E and FY2024E, implying a...
396 Views
Prodia (PRDA IJ) - Diagnosed for Growth
Prodia (PRDA IJ) continues to look dramatically undervalued versus its Indian diagnostic peers given its quality and growth prospects and remains...
574 Views
Prodia (PRDA IJ) - Keeping Indonesia Healthy Beyond COVID
Prodia (PRDA IJ) remains one of our top healthcare picks in Indonesia, which looks very undervalued versus its Indian peers, despite its high...
511 Views